You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.
Some parts of Europe turned to serology testing early to try to get a handle on the pandemic but had to quickly pull back after those tests performed abysmally.
Sema4 said it will provide SARS-CoV-2 viral and antibody testing to Connecticut residents including state employees and first responders.
Webb Diagnostic has placed an initial order worth about C$3.5 million for MedMira's RevealCOVID-19 Total Antibody Test.
The Dutch firm announced a deal earlier in the month to develop the test with Duke-NUS Medical School and the Diagnostics Development Hub in Singapore.
High-profile groups have proposed population-scale testing as key to a safe reopening, but the test numbers they propose dwarf current and projected lab capacity.
A UK official said that the government is working with other companies on developing tests with rapid turnaround times and noted a test from UK firm OptiGene.
The study aims to enroll 20,000 existing Biobank participants, as well as their adult children and grandchildren, from England, Scotland, and Wales.
Thermo Fisher will seek Emergency Use Authorization from the US FDA and international regulatory authorizations for the test over the next few weeks.
The high-volume version of the disposable serology test provides results in 10 minutes with a finger prick of blood.
The agency will now require commercial antibody test manufacturers to meet certain sensitivity and specificity thresholds.